Toxic Role of K+ Channel Oxidation in Mammalian Brain

Department of Physiology and Biophysics, University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08854, USA.
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.75). 03/2012; 32(12):4133-44. DOI: 10.1523/JNEUROSCI.6153-11.2012
Source: PubMed

ABSTRACT Potassium (K(+)) channels are essential to neuronal signaling and survival. Here we show that these proteins are targets of reactive oxygen species in mammalian brain and that their oxidation contributes to neuropathy. Thus, the KCNB1 (Kv2.1) channel, which is abundantly expressed in cortex and hippocampus, formed oligomers upon exposure to oxidizing agents. These oligomers were ∼10-fold more abundant in the brain of old than young mice. Oxidant-induced oligomerization of wild-type KCNB1 enhanced apoptosis in neuronal cells subject to oxidative insults. Consequently, a KCNB1 variant resistant to oxidation, obtained by mutating a conserved cysteine to alanine, (C73A), was neuroprotective. The fact that oxidation of KCNB1 is toxic, argues that this mechanism may contribute to neuropathy in conditions characterized by high levels of oxidative stress, such as Alzheimer's disease (AD). Accordingly, oxidation of KCNB1 channels was exacerbated in the brain of a triple transgenic mouse model of AD (3xTg-AD). The C73A variant protected neuronal cells from apoptosis induced by incubation with β-amyloid peptide (Aβ(1-42)). In an invertebrate model (Caenorhabditis elegans) that mimics aspects of AD, a C73A-KCNB1 homolog (C113S-KVS-1) protected specific neurons from apoptotic death induced by ectopic expression of human Aβ(1-42). Together, these data underscore a novel mechanism of toxicity in neurodegenerative disease.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Rho signaling regulates a variety of biological processes, but whether it is implicated in aging, remains an open question. Here we show that a guanine nucleotide exchange factor of the Dbl family, OSG-1, confers functional aging by dysregulating Rho GTPases activities in Caenorhabditis elegans. Thus, gene reporter analysis revealed widespread OSG-1 expression in muscle and neurons. Loss of OSG-1 gene function was not associated with developmental defects. In contrast, suppression of OSG-1 lessened loss of function (chemotaxis) in ASE sensory neurons subjected to conditions of oxidative stress generated either during natural aging or by oxidative challenges or by genetic mutations. RNAi analysis showed that OSG-1 was specific toward activation of RHO-1 GTPase signaling. RNAi further implicated actin-binding proteins ARX-3 and ARX-5, thus the actin cytoskeleton, as one of the targets of OSG-1/RHO-1 signaling. Taken together these data suggest that OSG-1 is recruited in conditions of oxidative stress, a hallmark of aging and contributes to promote loss of neuronal function by affecting the actin cytoskeleton via altered RHO-1 activity. Copyright © 2014, The Genetics Society of America.
    Genetics 12/2014; 199(2). DOI:10.1534/genetics.114.173500 · 4.87 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The whole-cell patch clamp method was used to study the effects of (±)3,4-methylenedioxyamphetamine (MDA) in hippocampal CA1 neurons from neonatal rats and in lung epithelial H1355 cells expressing Kv2.1. Extracellular application of MDA (30 μM) induced bursts of action potentials in hippocampal CA1 neurons exhibiting single spike action potentials without a bursting firing pattern, and promoted action potential bursts in hippocampal CA1 neurons exhibiting bursting firing of action potentials. Whereas MDA (30 and 100 μM) markedly decreased the delayed outward current in hippocampal CA1 neurons, MDA (100 μM) only slightly decreased the fast-inactivating K(+) current (IA) current. Furthermore, MDA (100 μM) substantially decreased the delayed outward current in the presence of 4-aminopyridine (4-AP; 3 mM), but did not significantly decrease the delayed outward current in the presence of tetraethylammonium (TEA; 30 mM). MDA (100 μM) also inhibited the current in H1355 cells expressing Kv2.1. Our results have shown that MDA inhibits the TEA-sensitive K(+) current in the hippocampus and the Kv2.1 current expressed in H1355 cells. These effects may contribute to the pharmacological and toxicological effects of MDA.
    Neuropharmacology 09/2014; 89. DOI:10.1016/j.neuropharm.2014.09.009 · 4.82 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Significance. Oxidative stress and damage are well established components of neurodegenerative diseases, contributing to neuronal death during disease progression. Here, we consider key K+ channels as target proteins which can undergo oxidative modulation, describe what is understood about how this influences disease progression, and consider regulation of these channels by gasotransmitters as a means of cellular protection. Recent Advances. Oxidative regulation of the delayed rectifier Kv2.1 and the Ca2+- and voltage-sensitive BK channel are established, but recent studies contest how their redox sensitivity contributes to altered excitability, progression of neurodegenerative diseases and healthy ageing. Critical Issues. Both Kv2.1 and BK channels have recently been established as target proteins for regulation by the gasotransmitters carbon monoxide and hydrogen sulfide. Establishing the molecular basis of such regulation, and exactly how this influences excitability and vulnerability to apoptotic cell death will determine whether such regulation can be exploited for therapeutic benefit. Future Directions. Developing a more comprehensive picture of the oxidative modulation of K+ channels (and indeed other ion channels) within the CNS in health and disease will allow us to better understand processes associated with healthy ageing as well as distinct processes underlying progression of neurodegenerative diseases. Advances in the growing understanding of how gasotransmitters can regulate ion channels, including redox-sensitive K+ channels, are a research priority for this field, and will establish their usefulness in design of future approaches for the treatment of such diseases.
    Antioxidants and Redox Signaling 10/2014; 22(6). DOI:10.1089/ars.2014.6007 · 7.67 Impact Factor